PRESS RELEASE published on 10/04/2023 at 21:30, 1 year 1 month ago EQS-Adhoc: EHC convenes EGM to extend business combination deadline and publishes repurchase document relating to redemption of public shares and proposed amendment of Warrant T&C
PRESS RELEASE published on 09/27/2023 at 18:30, 1 year 1 month ago European Healthcare Acquisition & Growth Company B.V. publishes its half-year report 2023
PRESS RELEASE published on 09/20/2023 at 12:30, 1 year 2 months ago EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V. announces intention to extend Business Combination Deadline, to offer redemption of Public Shares and to terminate all Public and Sponsor Warrants
PRESS RELEASE published on 08/07/2023 at 19:00, 1 year 3 months ago EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V. and Croma-Pharma GmbH terminate discussion on business combination
PRESS RELEASE published on 06/27/2023 at 12:55, 1 year 4 months ago General meeting of shareholders of European Healthcare Acquisition & Growth Company B.V. adopts all resolutions
PRESS RELEASE published on 06/26/2023 at 19:15, 1 year 4 months ago EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V. removes shareholders’ votes on proposed business combination with Croma-Pharma GmbH from agenda of general meeting
PRESS RELEASE published on 06/23/2023 at 19:30, 1 year 4 months ago EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V. received redemption notices with respect to EUR 185.85 million – minimum net cash condition is not yet fulfilled
PRESS RELEASE published on 06/21/2023 at 09:43, 1 year 5 months ago EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V.: Public disclosure of inside information
PRESS RELEASE published on 05/16/2023 at 23:15, 1 year 6 months ago European Healthcare Acquisition & Growth Company B.V convenes annual general meeting of shareholders and publishes shareholder circular relating to proposed business combination with Croma-Pharma GmbH
PRESS RELEASE published on 05/16/2023 at 00:45, 1 year 6 months ago EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V. and Croma-Pharma GmbH, agree on adjusted enterprise value of Croma, and Sponsors waive 20% sponsor shares and devalue 20% sponsor warrants
Published on 11/21/2024 at 14:00, 17 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 17 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 17 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 13:30, 47 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 12:35, 1 hour 42 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 2 hours 2 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 19 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 57 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 32 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 32 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
